H.C. Wainwright lowers Arvinas shares target amid Novartis licensing deal for ARV-766

Published on 11 Apr 2024 on Investing.com

Read the rest of the article

Start tracking your investments with Statfolio

We recently compiled a list of the 10 Best Small-Cap Biotech Stocks with Massive Potential Accord...

Insider Monkey · via Yahoo Finance 4 Dec 2024

We recently compiled a list of the 10 Best Small-Cap Stocks Ready To Explode. In this article, we...

Insider Monkey · via Yahoo Finance 19 Nov 2024

Arvinas Inc (NASDAQ:ARVN) is set to release its Q3 2024 earnings on Oct 30, 2024. The consensus...

GuruFocus.com · via Yahoo Finance 29 Oct 2024

We recently published a list of 8 Best Small-Cap Growth Stocks to Buy According to Analysts. In t...

Insider Monkey · via Yahoo Finance 23 Oct 2024

We recently compiled a list of the 10 Best Small-Cap Healthcare Stocks To Buy Now. In this articl...

Insider Monkey · via Yahoo Finance 19 Sep 2024

We recently compiled a list of the Top 10 Small-Cap Stocks with Highest Upside Potential. In this...

Insider Monkey · via Yahoo Finance 18 Jun 2024

Arvinas, Inc. (ARVN) is expected to deliver a year-over-year increase in earnings on higher reven...

Zacks via Yahoo Finance 26 Apr 2024

Novartis NVS entered into an exclusive strategic license agreement with a clinical-stage biotechn...

Zacks via Yahoo Finance 12 Apr 2024

Investing.com 11 Apr 2024

On Thursday, Stifel maintained a Buy rating on Arvinas Inc. (NASDAQ:ARVN) and increased the price...

Investing.com 11 Apr 2024